HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Christer Halldin Selected Research
Christer Halldin Research Topics
Disease
30
Alzheimer Disease (Alzheimer's Disease)
01/2024 - 01/2009
22
Schizophrenia (Dementia Praecox)
01/2024 - 01/2002
21
Parkinson Disease (Parkinson's Disease)
10/2023 - 10/2004
16
Mental Disorders (Mental Disorder)
01/2023 - 03/2002
13
Neurodegenerative Diseases (Neurodegenerative Disease)
10/2023 - 04/2008
13
Neuroinflammatory Diseases
01/2021 - 01/2009
10
Huntington Disease (Huntington's Disease)
12/2023 - 10/2011
9
Major Depressive Disorder (Major Depressive Disorders)
10/2021 - 11/2011
4
Cognitive Dysfunction
01/2024 - 01/2016
4
Gliosis
01/2023 - 01/2011
4
Breast Neoplasms (Breast Cancer)
12/2022 - 06/2010
4
Stroke (Strokes)
04/2016 - 11/2002
4
Amyloid Plaque
09/2015 - 08/2010
3
Neoplasms (Cancer)
12/2023 - 12/2021
3
Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 01/2019
3
Disease Progression
01/2020 - 01/2012
3
Infarction (Infarctions)
04/2016 - 01/2012
2
Brain Neoplasms (Brain Tumor)
11/2023 - 01/2020
2
Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021 - 01/2008
2
Dyskinesias (Dyskinesia)
01/2019 - 10/2018
2
Hypersensitivity (Allergy)
01/2018 - 02/2011
2
Ischemic Stroke
04/2016 - 09/2012
2
Obesity
02/2016 - 03/2014
2
Mood Disorders (Mood Disorder)
02/2015 - 10/2013
2
Anxiety Disorders (Anxiety Disorder)
02/2014 - 11/2013
2
Nervous System Diseases (Neurological Disorders)
06/2013 - 01/2010
2
Multiple Sclerosis
04/2013 - 01/2008
2
Juvenile Myoclonic Epilepsy
02/2012 - 06/2005
2
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2006 - 02/2005
2
Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2002 - 08/2002
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2023
1
Glioma (Gliomas)
11/2023
1
Multiple System Atrophy
10/2023
Drug/Important Bio-Agent (IBA)
18
Proteins (Proteins, Gene)
FDA Link
12/2022 - 01/2009
15
Dopamine (Intropin)
FDA Link
Generic
01/2023 - 05/2002
15
Serotonin (5 Hydroxytryptamine)
IBA
01/2023 - 03/2002
14
Biomarkers (Surrogate Marker)
IBA
08/2020 - 04/2008
12
Amyloid (Amyloid Fibrils)
IBA
01/2024 - 11/2009
10
Ligands
IBA
10/2023 - 01/2009
10
Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)
IBA
04/2023 - 09/2000
8
Enzymes
IBA
01/2023 - 01/2011
7
Dopamine Receptors (Dopamine Receptor)
IBA
01/2020 - 05/2002
6
Phosphoric Diester Hydrolases (Phosphodiesterases)
IBA
01/2020 - 06/2016
6
vinpocetine
IBA
09/2012 - 08/2002
5
Monoamine Oxidase (MAO)
IBA
01/2023 - 01/2011
5
Antipsychotic Agents (Antipsychotics)
IBA
01/2022 - 05/2002
5
Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)
IBA
10/2021 - 01/2003
5
5-HT1B Serotonin Receptor
IBA
01/2019 - 07/2008
5
Raclopride
IBA
05/2012 - 02/2005
4
2- (6- (methylamino)pyridin- 3- yl)- 1,3- benzothiazol- 6- ol
IBA
01/2024 - 11/2009
4
Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)
IBA
01/2019 - 09/2006
4
Amyloid beta-Peptides
IBA
01/2018 - 10/2010
3
5-HT1A Serotonin Receptor
IBA
01/2022 - 06/2005
3
GABA-A Receptors (GABA(A) Receptor)
IBA
01/2021 - 01/2009
3
Neurotransmitter Agents (Neurotransmitter)
IBA
03/2017 - 12/2014
3
Cannabinoid Receptors (Cannabinoid Receptor)
IBA
03/2014 - 02/2012
3
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
06/2013 - 06/2010
3
(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamide
IBA
04/2013 - 01/2008
3
Peptides (Polypeptides)
IBA
04/2012 - 01/2012
3
FLB 457
IBA
12/2006 - 01/2002
3
Dopamine D2 Receptors (Dopamine D2 Receptor)
IBA
12/2006 - 01/2002
2
pyrimidine
IBA
12/2023 - 01/2021
2
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
01/2022 - 11/2017
2
Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
IBA
01/2021 - 10/2016
2
polyglutamine
IBA
01/2021 - 01/2020
2
Metabotropic Glutamate 5 Receptor
IBA
01/2020 - 01/2018
2
Ketamine
FDA Link
Generic
01/2020 - 03/2015
2
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
01/2020 - 07/2019
2
Levodopa (L Dopa)
FDA Link
Generic
01/2019 - 10/2018
2
SCH 23390
IBA
01/2019 - 05/2002
2
metabotropic glutamate receptor 4
IBA
01/2019 - 10/2018
2
Antidepressive Agents (Antidepressants)
IBA
01/2019 - 08/2008
2
Vortioxetine
IBA
01/2019 - 10/2013
2
Insulin (Novolin)
FDA Link
12/2018 - 03/2015
2
Glutamic Acid (Glutamate)
FDA Link
01/2018 - 02/2009
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
03/2017 - 09/2015
2
Peroxidase (Myeloperoxidase)
IBA
09/2015 - 06/2015
2
AZD3241
IBA
09/2015 - 06/2015
2
Atomoxetine Hydrochloride (Strattera)
FDA Link
Generic
03/2015 - 09/2006
2
Norepinephrine (Noradrenaline)
FDA Link
Generic
03/2015 - 12/2014
2
Quetiapine Fumarate (Seroquel)
FDA Link
11/2013 - 11/2011
2
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
08/2013 - 09/2012
2
N- (5- fluoro- 2- phenoxyphenyl)- N- (2- fluoroethyl- 5- methoxybenzyl)acetamide
IBA
06/2013 - 04/2013
2
4- cyano- 1- (2- iodophenyl)- 5- (4- methoxyphenyl)- N- (piperidin- 1- yl)- 1H- pyrazole- 3- carboxamide
IBA
04/2012 - 02/2012
2
N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropane
IBA
02/2012 - 02/2005
2
Clozapine (Clozaril)
FDA Link
Generic
11/2011 - 03/2003
2
multidrug resistance-associated protein 1
IBA
02/2011 - 06/2010
1
AMPA Receptors (AMPA Receptor)
IBA
01/2024
1
FAPI-46
IBA
12/2023
1
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
IBA
12/2023
1
Huntingtin Protein
IBA
12/2023
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
11/2023
1
DNA (Deoxyribonucleic Acid)
IBA
11/2023
1
Methyltransferases
IBA
11/2023
1
Synucleins
IBA
10/2023
1
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
06/2023
1
Nerve Growth Factors (Neurotrophins)
IBA
01/2023
Therapy/Procedure
4
Therapeutics
01/2017 - 01/2012
2
Aftercare (After-Treatment)
10/2021 - 09/2015
2
Oral Administration
03/2017 - 08/2002